相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Reassessing the Host Defense Peptide Landscape
Evan F. Haney et al.
FRONTIERS IN CHEMISTRY (2019)
Rhesus θ-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment
Jordanna G. Jayne et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Fungicidal Potency and Mechanisms of theta-Defensins against Multidrug-Resistant Candida Species
Virginia Basso et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Macrocyclic theta-defensins suppress tumor necrosis factor-alpha ( TNF-alpha) shedding by inhibition of TNF-alpha-converting enzyme
Justin B. Schaal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Antifungal Potential of Host Defense Peptide Mimetics in a Mouse Model of Disseminated Candidiasis
Mobaswar Hossain Chowdhury et al.
JOURNAL OF FUNGI (2018)
Suppression and resolution of autoimmune arthritis by rhesus θ-defensin-1, an immunomodulatory macrocyclic peptide
Justin B. Schaal et al.
PLOS ONE (2017)
Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism
Lorenzo P. Menzel et al.
SCIENTIFIC REPORTS (2017)
An Immunomodulatory Peptide Confers Protection in an Experimental Candidemia Murine Model
Camila G. Freitas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation
Timothy J. Bensman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa
Paul M. Beringer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Is there an emerging need for new antifungals?
John R. Perfect
EXPERT OPINION ON EMERGING DRUGS (2016)
Antifungal agents and liver toxicity: a complex interaction
Frank P. Tverdek et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2016)
Pathogenesis of Candida albicans biofilm
Christina Tsui et al.
PATHOGENS AND DISEASE (2016)
New Horizons in Antifungal Therapy
Kaila M. Pianalto et al.
JOURNAL OF FUNGI (2016)
Candida albicans Biofilms and Human Disease
Clarissa J. Nobile et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 69 (2015)
Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality
M. Slavin et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Invasive Candidiasis
Bart Jan Kullberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
How to bolster the antifungal pipeline
David W. Denning et al.
SCIENCE (2015)
Immune defence against Candida fungal infections
Mihai G. Netea et al.
NATURE REVIEWS IMMUNOLOGY (2015)
A neglected epidemic: fungal infections in HIV/AIDS
Darius Armstrong-James et al.
TRENDS IN MICROBIOLOGY (2014)
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Terry Roemer et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Epidemiology and risk factors for invasive candidiasis
Nur Yapar
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2014)
Anti-GM-CSF Autoantibodies in Patients with Cryptococcal Meningitis
Lindsey B. Rosen et al.
JOURNAL OF IMMUNOLOGY (2013)
θ-Defensins: Cyclic Peptides with Endless Potential
Robert I. Lehrer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Rhesus Macaque Theta Defensins Suppress Inflammatory Cytokines and Enhance Survival in Mouse Models of Bacteremic Sepsis
Justin B. Schaal et al.
PLOS ONE (2012)
Hidden Killers: Human Fungal Infections
Gordon D. Brown et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
Sheena D. Singh-Babak et al.
PLOS PATHOGENS (2012)
Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The contribution of mouse models to our understanding of systemic candidiasis
Edina K. Szabo et al.
FEMS MICROBIOLOGY LETTERS (2011)
Rhesus macaque θ-defensin isoforms: expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities
Prasad Tongaonkar et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Pathogenesis and treatment of oral candidosis
David Williams et al.
Journal of Oral Microbiology (2011)
Breakthrough Invasive Candidiasis in Patients on Micafungin
Christopher D. Pfeiffer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
An insight into the antifungal pipeline: selected new molecules and beyond
Luis Ostrosky-Zeichner et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
MICs and minimum fungicidal concentrations of amphotericin B, itraconazole, posaconazole and terbinafine in Sporothrix schenckii
Carolina Pereira Silveira et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Rhesus Theta-Defensin Prevents Death in a Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Pulmonary Disease
Christine L. Wohlford-Lenane et al.
JOURNAL OF VIROLOGY (2009)
Neutrophil Extracellular Traps Contain Calprotectin, a Cytosolic Protein Complex Involved in Host Defense against Candida albicans
Constantin F. Urban et al.
PLOS PATHOGENS (2009)
In Vitro Activity of the Antifungal Plant Defensin RsAFP2 against Candida Isolates and Its In Vivo Efficacy in Prophylactic Murine Models of Candidiasis
Patricia M. Tavares et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Isolation, Synthesis, and Antimicrobial Activities of Naturally Occurring θ-Defensin Isoforms from Baboon Leukocytes
Angie E. Garcia et al.
INFECTION AND IMMUNITY (2008)
A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing
Christopher G Pierce et al.
Nature Protocols (2008)
Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents
Joseph Meletiadis et al.
PHARMACOGENOMICS (2008)
Paradoxical effect of echinocandins across Candida species in vitro:: Evidence for echinocandin-specific and Candida species-related differences
Georgios Chamilos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor
Kevin L. Winthrop
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Antifungal drug resistance: limited data, dramatic impact?
Thomas R. Rogers
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice
DM MacCallum et al.
MYCOSES (2005)
Determination of fungicidal activities against yeasts and molds: Lessons learned from bactericidal testing and the need for standardization
MA Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Candida infections of medical devices
EM Kojic et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Paradoxical effect of caspofungin:: Reduced activity against Candida albicans at high drug concentrations
DA Stevens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The damage-response framework of microbial pathogenesis
A Casadevall et al.
NATURE REVIEWS MICROBIOLOGY (2003)
Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species
E Cantón et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2003)
Evolution of primate theta-defensins: a serpentine path to a sweet tooth
TX Nguyen et al.
PEPTIDES (2003)
Candida biofilms and their role in infection
LJ Douglas
TRENDS IN MICROBIOLOGY (2003)
Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study
A Espinel-Ingroff et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Homodimeric θ-defensins from Rhesus macaque leukocytes -: Isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides
D Tran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use
W Hope et al.
JOURNAL OF HOSPITAL INFECTION (2002)
Biofilm formation by the fungal pathogen Candida albicans:: Development, architecture, and drug resistance
J Chandra et al.
JOURNAL OF BACTERIOLOGY (2001)